ArticleCureus2025
Clinical Factors Associated With Intracranial Aneurysms in Patients With Autosomal Dominant Polycystic Kidney Disease.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Endothelial dysfunction: A central mechanism linking autosomal dominant polycystic kidney disease and intracranial aneurysms (Review).International journal of molecular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Autosomal dominant polycystic kidney disease (ADPKD) is associated with an increased prevalence of intracranial aneurysms (IAs), but the clinical factors influencing IA development remain unclear. This study aimed to identify the clinical factors associated with the presence or absence of IAs in patients with ADPKD. Methods We conducted a retrospective cohort study of 138 Japanese patients with ADPKD who underwent neuroradiological imaging between January 2004 and December 2020. Patients were categorized into IA (n=30) and non-IA (n=108) groups. Clinical characteristics, including age at ADPKD diagnosis, dialysis status, comorbidities, and family history of IA, were compared using univariate and multivariate analyses. Correlation between age at IA diagnosis and age at dialysis initiation was also examined. Results The prevalence of IA was 21.7%, with multiple IAs in 30.0% of affected patients and subarachnoid hemorrhage (SAH) in 23.3%. The most common IA locations were the internal carotid artery (35.7%), middle cerebral artery (28.6%), and anterior cerebral artery (21.4%). Patients in the IA group were older at ADPKD diagnosis (54.5±13.5 vs. 46.8±13.7 years, p<0.01) and more frequently on dialysis (60.0% vs. 34.3%, p<0.05). Multivariate analysis identified older age at ADPKD diagnosis and dialysis use as independent factors associated with IA. Among dialysis patients, age at IA diagnosis correlated positively with age at dialysis initiation (r=0.885, p<0.0001). Conclusion IAs were detected in approximately one-fifth of ADPKD patients, particularly in those of advanced age and on dialysis. The statistically significant and positive correlation between IA diagnosis age and dialysis initiation suggests a relationship between IA development and renal function decline. Targeted IA screening, especially in elderly ADPKD patients and at the time of dialysis initiation, with periodic reimaging for high-risk individuals, may improve early detection and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.